you are here: Home News Generic Drugs

Generic Drugs

Indian generics likely insulated from Trump's drug pricing order, but Sun Pharma faces pressure
India rejects European FTA bloc's 'data exclusivity' demand to protect generic drug firms' interest
Indian pharma's growth expectations are trending downwards
Why NMC’s proposal on generic drugs, professional conduct of doctors was a wrong prescription
NMC puts on hold its regulations mandating doctors to prescribe generic drugs, bar them from endorsing any drug brand
Sun Pharma's investors face a risk from India's unbranded generic drug push
Chart of the Day: Pharma market growth momentum healthy, but risks lurk
Zydus Lifesciences gets final approval from USFDA for Azithromycin tablets
Generic versions of diabetes drug Sitagliptin now available at govt stores at affordable prices
Novartis to spin off generics business Sandoz next year
Endless growth prospects for generics in India, Jan Aushadhi pharmacies aim to match growing demand: PMBI CEO Ravi Dadhich
Monthly revenue from Jan Aushadhi shops cross Rs 100 crore for first time
India woos ASEAN with generics production, vaccines; wants support in IPR waiver
Veterans Unpacked | D.S. Brar: "Your network is your net worth, and your credibility is your currency"
Reporter's Take | How safe are generic drugs?
Lupin denies price manipulation allegations, says will defend antitrust lawsuit in US
Comment | Cipla takes a calculated risk with generic Sensipar launch
Comment | US FDA to get a new chief, watch for side effects on pharma shares
Modi’s proposed law on docs using generic name in prescriptions gets MSF vote
Govt to make generic drugs mandatory
Torrent Pharma to acquire clutch of generic brands from Novartis
Despite regulatory issues, pharma regulators positive on outlook
Q3 results: Five trends to watch out from Indian drugmakers
Serial testers, hasty checks: India's flawed generic drug trials
Pharma industry eyes generic drug exports to Japanese market

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Generic Drugs

Indian generics likely insulated from Trump's drug pricing order, but Sun Pharma faces pressure

India rejects European FTA bloc's 'data exclusivity' demand to protect generic drug firms' interest

Indian pharma's growth expectations are trending downwards

Why NMC’s proposal on generic drugs, professional conduct of doctors was a wrong prescription

NMC puts on hold its regulations mandating doctors to prescribe generic drugs, bar them from endorsing any drug brand

Sun Pharma's investors face a risk from India's unbranded generic drug push

Chart of the Day: Pharma market growth momentum healthy, but risks lurk

Zydus Lifesciences gets final approval from USFDA for Azithromycin tablets

Generic versions of diabetes drug Sitagliptin now available at govt stores at affordable prices

Novartis to spin off generics business Sandoz next year

Endless growth prospects for generics in India, Jan Aushadhi pharmacies aim to match growing demand: PMBI CEO Ravi Dadhich

Monthly revenue from Jan Aushadhi shops cross Rs 100 crore for first time

India woos ASEAN with generics production, vaccines; wants support in IPR waiver

Veterans Unpacked | D.S. Brar: "Your network is your net worth, and your credibility is your currency"

Reporter's Take | How safe are generic drugs?

Lupin denies price manipulation allegations, says will defend antitrust lawsuit in US

Comment | Cipla takes a calculated risk with generic Sensipar launch

Comment | US FDA to get a new chief, watch for side effects on pharma shares

Modi’s proposed law on docs using generic name in prescriptions gets MSF vote

Govt to make generic drugs mandatory

Torrent Pharma to acquire clutch of generic brands from Novartis

Despite regulatory issues, pharma regulators positive on outlook

Q3 results: Five trends to watch out from Indian drugmakers

Serial testers, hasty checks: India's flawed generic drug trials

Pharma industry eyes generic drug exports to Japanese market